Phoenix PharmaLabs is a preclinical drug company focused on the development of new potent, safe, non-addictive treatments for pain and addiction. Opioids are the most powerful analgesics for treatment of moderate to severe pain, but they are plagued by serious side effects including abuse and addiction, constipation, respiratory depression, and death from overdose. Phoenix is addressing the opioid crisis head-on in this $30 billion market.